Blue Matter Blog
June 27, 2018
Part IV in a Series on Rare Diseases In Part I of this series, we introduced the fact that rare disease (RD) patients are quite special. The same is true for the specialists who treat them. In RD markets, these dynamics create the need for patient-centric treatment approaches and a “high-touch” business model with key …
June 13, 2018
Part III in a Series on Rare Diseases In parts I and II of this series, we provided an overview of the special commercial challenges associated with rare disease (RD) therapies, and we took a deeper dive into one of the most obvious: Finding patients. In this installment, we explore rare disease Centers of Excellence …
By pressing the “Accept Cookies” button, the user accepts all Cookies on the Website. View our Cookie Statement.